StonvexLoading…
StonvexStonvexStonvexCore line items from AMG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $587.50M | $544.90M | $2.07B | $1.52B | $989.80M |
Operating Income | Not available | $192.90M | $1.19B | $660.80M | $298.20M |
Net Income | Not available | $110.40M | $716.60M | $369.00M | $156.60M |
EPS (Diluted) | $7.77 | $3.84 | $22.74 | $11.83 | $5.01 |
Total Assets | Not available | $9.40B | $9.21B | $8.93B | $8.81B |
Total Liabilities | Not available | $5.15B | $4.79B | $4.39B | $4.33B |
Cash & Equivalents | Not available | $376.10M | $586.00M | $476.10M | $361.00M |
Free Cash Flow OCF − CapEx | Not available | $295.50M | $967.10M | $712.60M | $436.70M |
Shares Outstanding | Not available | 27.50M | 33.00M | 33.00M | 32.30M |